Researcher
Peter Vandenabeele
- Keywords (Ghent University):Cell death and inflammation
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Ghent University):Biophysics, Molecular and cell biology, Laboratory medicine, Microbiology, Systems biology, Plant biology, Medicinal and biomolecular chemistry, Molecular and cell biology not elsewhere classified
Affiliations
- Vandenabeele Lab (Research group)
Responsible
From1 Jan 2017 → Today - Board of Governors/Executive Board (Administrative office)
Member
From1 Oct 2012 → Today - Department of Biomedical molecular biology (Department)
Member
From1 Oct 1993 → Today - Department of Plant Biotechnology and Bioinformatics (Department)
Member
From1 Jan 1993 → 30 Sep 1993
Projects
51 - 60 of 69
- Total-relfexion X-ray Fluorescence (TXRF) instrumentationFrom22 Jul 2010 → 30 Jun 2016Funding: Hercules - Small and Medium size research infrastructure
- Danger-associated molecular patters: revealing the molecular signals dictating the communication between dying cells with the immune systemFrom1 Jan 2010 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
- Apoptosis, necrosis and autophagy: a comparative study of the impact dying cells on innate immunityFrom1 Jan 2010 → 31 Dec 2012Funding: FWO research grant KAN
- Identification of RIP3 substrates and their role in necrotic cell death.From1 Oct 2009 → 26 Feb 2015Funding: IWT personal funding - specialisation scholarships
- NRAGE, a novel regulator of RIP2 dependent NOD signaling in immune responsesFrom1 Oct 2009 → 30 Sep 2012Funding: BOF - Other initiatives, FWO fellowships
- Euregional Platform for Advancing Cancer Treatment IIFrom1 Apr 2009 → 31 Jan 2013Funding: Other EU initiatives out of framework
- Study of the molecular role of caspase-14 using transgenic Mouse modelsFrom1 Jan 2009 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
- Cell death activity regulation in inflammation and cancerFrom1 Jan 2009 → TodayFunding: BOF - Methusalem, Methusalem
- Research into the role and mechanism of caspase-7 in immunomodulation and in immunopathologiesFrom1 Oct 2008 → 30 Sep 2012Funding: FWO fellowships, BOF - Other initiatives
- Identification and validation of protein substrates and interactors of RIP1 during necrotic cell deathFrom1 Oct 2008 → 30 Sep 2010Funding: BOF - Doctoral projects
Publications
1 - 10 of 306
- Type 1 immunity enables neonatal thymic ILC1 production(2024)
Authors: Peter Tougaard, Mario Ruiz Pérez, Wolf Steels, Jelle Huysentruyt, Bruno Verstraeten, Jessica Vetters, Tatyana Divert, Amanda Gonçalves, Ria Roelandt, Nozomi Takahashi, et al.
- Caspase inhibition modulates monocyte-derived macrophage polarization in damaged tissues(2023)
Authors: Stéphanie Solier, Michele Mondini, Lydia Meziani, Arnaud Jacquel, Catherine Lacout, Tom Vanden Berghe, Yvon Julé, Jean-Claude Martinou, Gérard Pierron, Julie Rivière, et al.
- Systematic compositional analysis of exosomal extracellular vesicles produced by cells undergoing apoptosis, necroptosis and ferroptosis(2023)
Authors: Benjamin Cappe, Mike Vadi, Eliza Sack, Ludivine Wacheul, Bruno Verstraeten, Sara Dufour, Julien Franck, Wei Xie, Francis Impens, An Hendrix, et al.
- NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis(2023)
Authors: Yves Dondelinger, Dario Priem, Jon Huyghe, Tom Delanghe, Peter Vandenabeele, Mathieu Bertrand
- Trial watch : chemotherapy-induced immunogenic cell death in oncology(2023)
Authors: Jenny Sprooten, Raquel S Laureano, Isaure Vanmeerbeek, Jannes Govaerts, Stefan Naulaerts, Daniel M Borras, Lisa Kinget, Jitka Fucikova, Radek Spisek, Lenka Palova Jelinkova, et al.
- Pore-forming proteins as drivers of membrane permeabilization in cell death pathways(2023)
Authors: Peter Vandenabeele, Geert Bultynck, Savvas Savvides
Pages: 312 - 333 - Apoptotic cell death in disease : current understanding of the NCCD 2023(2023)
Authors: Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A Aaronson, John M Abrams, Dieter Adam, Massimiliano Agostini, Patrizia Agostinis, Emad S Alnemri, Lucia Altucci, et al.
Pages: 1097 - 1154 - Molecular mechanisms of nemorosone-induced ferroptosis in cancer cells(2023)
Authors: Roberto Fernández-Acosta, Jurgen Caroen, Bartosz Wiernicki, Daniel Alvarez-Alminaque, Johan Van der Eycken, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L. Pardo-Andreu
- RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD(2023)
Authors: Hannelore Van Eeckhoutte, Chantal Donovan, Richard Y. Kim, Thomas M. Conlon, Meshal Ansari, Haroon Khan, Ranjith Jayaraman, Nicole G. Hansbro, Yves Dondelinger, Tom Delanghe, et al.
- Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression(2023)
Authors: Emily Van San, Angela Debruyne, Geraldine Veeckmans, Yulia Y. Y. Tyurina, Vladimir A. A. Tyurin, Hao Zheng, Sze Men Choi, Koen Augustyns, Geert van Loo, Bernhard Michalke, et al.
Pages: 2092 - 2103
Patents
1 - 6 of 6
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- Targeting of Interleukin-1 and -18 in treatment of septic shock (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)